CG Oncology, Inc. (CGON) Cash Flow Statement
CG Oncology, Inc. (CGON) generated -$178.5M of operating cash flow over the twelve months to 2026-06-30, spent $876000 on capital expenditure and had free cash flow of -$179.3M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CGONCG Oncology, Inc.Follow CGON — free
—
Price chart with a free account
- Market cap
- 5.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 12 Nov, in 19 days
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Operating cash flow | -0.05 | -0.08 | -0.13 | -0.18 | |
| Capital expenditure | — | 0.00 | 0.00 | -0.00 | |
| Free cash flow | — | -0.08 | -0.13 | -0.18 | |
| Stock-based compensation | 0.00 | 0.01 | 0.03 | — |
USD billions · SEC XBRL
CG Oncology, Inc. — questions
- What is CG Oncology, Inc.'s operating cash flow?
- -$178.5M over the twelve months to 2026-06-30.
- How much does CG Oncology, Inc. spend on capital expenditure?
- $876000 over the twelve months to 2026-06-30.
- What is CG Oncology, Inc.'s free cash flow?
- -$179.3M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from CG Oncology, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.